Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 295-556-6 | CAS number: 92077-08-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
Oral:
female rats: LD50: 1000-2000 mg/kg bw
Dermal:
female/male rats: LD50> 2000 mg/kg bw
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1981-01-27 to 1981-02-12
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study equivalent to guideline. non-GLP
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- female wistar rats (Hoe WISKf(SPF71))
body weight: 200-222g (x = 209,2 g, s = ± 7,69 g, n = 20) - Route of administration:
- oral: gavage
- Vehicle:
- other: sesam oil
- Details on oral exposure:
- oral gavage of 25%-solution in sesam oil (25 glad 100 ml)
- Doses:
- 1000 mg/kg bw, 2000 mg/kg bw
- No. of animals per sex per dose:
- 10
- Control animals:
- no
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 1 000 - < 2 000 mg/kg bw
- Mortality:
- 1000 mg/kg bw: 1/10
2000 mg/kg bw: 10/10
Fatally poisoned animals died within 1-5 days after application. - Clinical signs:
- other: The following symptoms were observed: passivity, squat, long-legged position, stomach tightened. Edge-fed, hyporeflexia, narrowed eyelids and bristling hair.
- Gross pathology:
- The section of dead animals showed macroscopically the following findings: red gastrointestinal-intestinal tract, small intestine with reddish-brown fluid filled, lung colored intense red, sometimes mottled brownish, liver spotted pale brown, adrenal gland stained dark red.
The section of the surviving test animals showed no macroscopically findings. - Interpretation of results:
- Toxicity Category IV
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The LD50 of the substance is in the range of 1000-2000mg/kg bw.
- Executive summary:
The acute oral toxicity of the substance was tested by oral gavage of 25% solution in sesam oil to 10 femal wistar rats per dose (1000 + 2000 mg/kg bw). At low dose 1/10 and at high dose 10/10 animals died within 1-5h after application.
The LD50 was determined to be in the range of 1000 -2000 mg/kg bw.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 1 000 mg/kg bw
- Quality of whole database:
- Reliable and robust; study equicalent to guidline
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2011-05-23 to 2011-09-14
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1200 (Acute Dermal Toxicity)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- (Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, München, Germany)
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- - Full barrier in an air-conditioned room
- Temperature: 22 +/- 3 °C
- Relative humidity: 55 +/- 10%
- Artificial light, sequence being 12 hours light, 12 hours dark
- Air change: 10 x / hour
- Free access to Altromin 1324 maintenance diet for rats and mice (lot no. 1130)
- Free access to tap water, sulphur acidified to a pH value of approximately 2.8 (drinking water, municipal residue control, microbiological controls at regular intervals)
- The animals were kept individually in IVC cages, type III H, polysulphone cages on Altromin saw fibre bedding (lot no. 040311)
- Certificates of food, water and bedding are filed at BSL BIOSERVICE
- Adequate acclimatisation period (at least five days) under laboratory conditions - Type of coverage:
- semiocclusive
- Details on dermal exposure:
- Preparation of the Animals:
The animals were marked for individual identification by tail painting.
Approximately 24 hours before the test, the fur was removed from the dorsal area of the trunk using an electric clipper.
Care was taken to avoid abrading the skin, and only animals with healthy intact skin were used.
No less than 10% of the body surface was cleared for the application.
Prior to the application a detailed clinical observation was made of all animals.
Application:
The test item was applied at a single dose, uniformly over an area which was approximately 10% of the total body surface.
The test item was held in contact with the skin by a dressing throughout a 24-hour period.
The dressing consisted of a gauze-dressing and non-irritating tape and was fixed with an additional dressing in a suitable manner. - Duration of exposure:
- The test item was held in contact with the skin throughout a 24-hour period.
At the end of the exposure period the residual test item was removed using
aqua ad injectionem (Berlin Chemie, lot no. 0195A191, expiry date: 04/2013). - Doses:
- The test item was applied at a single dose of 2000 mg/kg body weight to each animal.
- No. of animals per sex per dose:
- 5 male and 5 female
- Control animals:
- not required
- Details on study design:
- Observation period:
All animals were observed for 14 days after dosing
Weight Assessment:
The animals were weighed on day 1 (prior to the application) and on days 8 and 15.
Clinical Examination:
careful clinical examination was made several times on the day of dosing (at least once during the first 30 minutes and with special attention given during the first 4 hours post-dose). As soon as symptoms were noticed they were recorded. Thereafter, the animals were observed for clinical signs once daily until the end of the observation period. All abnormalities were recorded.
Cageside observations included changes in the skin and fur, eyes and mucous membranes. Also respiratory, circulatory, autonomic and central nervous systems and somatomotor activity and behaviour pattern were examined. Attention was directed to observations of tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma.
Pathology:
At the end of the observation period the surviving animals were sacrificed with an overdosage of pentobarbital injected intraperitoneally (Narcoren®, Merial) at the dosage of approximately 8 mL/kg bw. All animals were subjected to gross necropsy. All gross pathological changes were recorded and in case of findings the tissues were preserved for a possible histopathological evaluation. The preserved tissues of which no histopathological evaluation was made will be discarded 3 months after the release of the final report unless otherwise agreed upon with the sponsor.
Evaluation of Results:
Individual reactions of each animal were recorded at each time of observation.
Toxic response data were recorded by sex and dose level.
Nature, severity and duration of clinical observations were described.
The body weight changes were summarised in a tabular form.
Necropsy findings were described.
On the basis of the test results, the test item may be classified in one of the following classes in conformity with the criteria given in Annex VI to Commission Directive 2001/59/EC:
• Very toxic
Substances and preparations shall be classified as very toxic, and assigned the symbol “T+” and indication of danger “very toxic” in accordance with the criteria specified below:
R27 Very toxic in contact with skin
- LD50 dermal, rat or rabbit: <= 50 mg/kg
• Toxic
Substances and preparations shall be classified as toxic, and assigned the symbol “T” and indication of danger “toxic” in accordance with the criteria specified below. Risk phrases shall be assigned in accordance with the following criteria:
R24 Toxic in contact with skin
- LD50 dermal, rat or rabbit: 50 < LD50 <= 400 mg/kg
• Harmful
Substances and preparations shall be classified as harmful, and assigned the symbol “Xn” and indication of danger “harmful” in accordance with the criteria specified below. Risk phrases shall be assigned in accordance with the following criteria:
R21 Harmful in contact with skin
- LD50 dermal, rat or rabbit: 400 < LD50 <= 2000 mg/kg
On the basis of the test results, the following risk phrases may be assigned in conformity with the criteria given in Annex I of Regulation (EC) 1272/2008:
Category 1: LD50 <= 50 mg/kg. DANGER. Skull and crossbones in diamond. Fatal in contact with skin.
Category 2: LD50 > 50 mg/kg <= 200 mg/kg. DANGER. Skull and crossbones in diamond. Fatal in contact with skin.
Category 3: LD50 > 200 mg/kg <= 1000 mg/kg. DANGER. Skull and crossbones in diamond. Toxic in contact with skin.
Category 4: LD50 > 1000 mg/kg <= 2000 mg/kg. WARNING. Exclamation point in diamond. Harmful in contact with skin.
On the basis of the test results, the following risk phrases may be assigned in conformity with the criteria given in GHS - Globally Harmonized System of Classification and Labelling of Chemicals, third revised edition, July 2009:
Category 1: LD50 <= 50 mg/kg. DANGER. Skull and crossbones in diamond. Fatal in contact with skin.
Category 2: LD50 > 50 mg/kg <= 200 mg/kg. DANGER. Skull and crossbones in diamond. Fatal in contact with skin.
Category 3: LD50 > 200 mg/kg <= 1000 mg/kg. DANGER. Skull and crossbones in diamond. Toxic in contact with skin.
Category 4: LD50 > 1000 mg/kg <= 2000 mg/kg. WARNING. Exclamation point in diamond. Harmful in contact with skin.
Category 5: LD50 > 2000 mg/kg <= 5000 mg/kg. WARNING. No symbol. May be harmful in contact with skin. - Statistics:
- According to OECD guidelines, the biological relevance of the results is the criterion for the interpretation of results,
a statistical evaluation of the results is not regarded as necessary. - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- No mortality was observed
- Clinical signs:
- other: No treatment-related effects were observed.
- Gross pathology:
- No treatment-related effects were observed.
- Other findings:
- Erythema grade 1 – 2 was observed in all animals.
Oedema grade 1 was observed in 3 of 5 male and all female animals.
Desquamation and eschar were observed in all animals. Scratches were observed in 1 of 5 male animals.
The signs of irritation were not completely reversible within the observation period. - Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of the present study, single dermal application of the test item Tripropenyl succinic anhydride
to rats at a dose of 2000 mg/kg body weight was associated with neither mortality nor signs of toxicity but signs of irritation.
The dermal LD50 was determined to be > 2000 mg Tripropenyl succinic anhydride / kg body weight.
In conformity with the criteria given in Annex VI to Commission Directive 2001/59/EC the test item
Tripropenyl succinic anhydride has no obligatory labelling requirement for percutaneous toxicity.
According to Annex I of Regulation (EC) 1272/2008 the test item Tripropenyl succinic anhydride
has no obligatory labelling requirement for percutaneous toxicity and is unclassified.
According to OECD-GHS (Globally Harmonized Classification System) the test item
Tripropenyl succinic anhydride has no obligatory labelling requirement for percutaneous toxicity and is unclassified. - Executive summary:
Summary Results
On the basis of the test results given below and in conformity with the criteria given in Annex VI to Commission Directive 2001/59/EC, the substance should be:
classified asvery toxic
classified astoxic
classified as harmful
not classified
X
limit test
X
On the basis of the test results given below and in conformity with the criteria given in inAnnex I of Regulation (EC) 1272/2008, the substance should be:
classified into category 1
classified into category 2
classifiedinto category 3
classifiedinto category 4
not classified
X
On the basis of the test results given below and in conformity with the criteria given in inOECD-GHS (Globally Harmonized System of Classification and Labelling of Chemicals), the substance should be:
classified into category 1
classified into category 2
classifiedinto category 3
classifiedinto category 4
classifiedinto category 5
not classified
X
LD50: > 2000 mg /kg bw
Species/strain: WISTAR Crl: WI(Han) rats
Vehicle (moistening): no vehicle used
Number of animals: 5 male and 5 female
Duration of exposure: 24 hours
Method: OECD 402, EC 440/2008, OPPTS 870.1200
Results per Step
Sex
Dose
(mg/kg bw)Number
of AnimalsNumber
of Intercurrent Deathsmale
2000
5
0
female
2000
5
0
Signs of toxicity related to dose level used, time of onset and duration:
No treatment-related effects were observed.
Effect on organs (related to dose level):
No treatment-related effects were observed.
Signs of irritation:
Erythema grade 1 – 2 was observed in all animals. Oedema grade 1 was observed in 3 of 5 male and all female animals.
Desquamation and eschar were observed in all animals. Scratches were observed in 1 of 5 male animals.
The signs of irritation were not completely reversible within the observation period.
Conclusion
Under the conditions of the present study, single dermal application of the test item Tripropenyl succinic anhydride to rats
at a dose of 2000 mg/kg body weight was associated with neither mortality nor signs of toxicity but signs of irritation.
The dermal LD50 was determined to be > 2000 mg Tripropenyl succinic anhydride/ kg body weight.
In conformity with the criteria given inAnnex VI to Commission Directive 2001/59/EC the test item Tripropenyl succinic anhydride
has no obligatory labelling requirement for percutaneous toxicity.
According to Annex I of Regulation (EC) 1272/2008 the test item Tripropenyl succinic anhydride has no obligatory labelling
requirement for percutaneous toxicity and is unclassified.
According to OECD-GHS (Globally Harmonized Classification System) the test item Tripropenyl succinic anhydride has no obligatory labelling requirement for percutaneous toxicity and is unclassified.
Reference
Table Clinical Signs of Systemic Toxicity – Individual Data - Males:
Animal |
Time of |
Observations (for Signs of Dermal Irritation, see Table 5) |
21/ male / |
during the whole observation period |
no signs of toxicity |
22/ male / |
during the whole observation period |
no signs of toxicity |
23/ male / |
30 min., |
no signs of toxicity |
1 day |
nasal discharge |
|
2 days until the end of the observation period |
no signs of toxicity |
|
24/ male / |
30 min., |
no signs of toxicity |
1 day |
nasal discharge |
|
2 days until the end of the observation period |
no signs of toxicity |
|
25/ male / |
30 min., |
no signs of toxicity |
1 day |
nasal discharge |
|
2 days until the end of the observation period |
no signs of toxicity |
Table Clinical Signs of Systemic Toxicity – Individual Data – Females:
Animal |
Time of |
Observations (for Signs of Dermal Irritation, see Table 5) |
26/ female / 2000 mg/kg bw |
during the whole observation period |
no signs of toxicity |
27/ female / 2000 mg/kg bw |
30 min., |
no signs of toxicity |
1 day |
nasal discharge |
|
2 days until the end of the observation period |
no signs of toxicity |
|
28/ female / 2000 mg/kg bw |
30 min., |
no signs of toxicity |
1 day |
nasal discharge |
|
2 days until the end of the observation period |
no signs of toxicity |
|
29/ female / 2000 mg/kg bw |
during the whole observation period |
no signs of toxicity |
30/ female / 2000 mg/kg bw |
30 min., |
no signs of toxicity |
1 day |
nasal discharge |
|
2 days until the end of the observation period |
no signs of toxicity |
Table Skin Irritation – Individual Data – Males:
Day after Start of Application |
Animal No. 21 |
Animal No. 22 |
Animal No. 23 |
Animal No. 24 |
Animal No. 25 |
|||||
E/O |
Comments |
E/O |
Comments |
E/O |
Comments |
E/O |
Comments |
E/O |
Comments |
|
day 2 |
1/1 |
nsf |
1/0 |
nsf |
1/1 |
nsf |
2/1 |
nsf |
1/0 |
nsf |
day 3 |
1/0 |
s |
1/0 |
nsf |
1/0 |
nsf |
1/1 |
nsf |
1/0 |
nsf |
day 4 |
1/0 |
d, es |
1/0 |
d, es |
1/0 |
d |
1/1 |
d |
1/0 |
d, es |
day 5 |
0/0 |
d |
0/0 |
d, es |
1/0 |
d |
1/0 |
d |
1/0 |
d, es |
day 6 |
0/0 |
d |
0/0 |
d, es |
0/0 |
d |
0/0 |
d |
0/0 |
d, es |
day 7 |
0/0 |
d |
0/0 |
d |
0/0 |
d |
0/0 |
d |
0/0 |
d |
day 8 |
0/0 |
d, es |
0/0 |
nsf |
0/0 |
d, es |
0/0 |
d |
0/0 |
d, es |
day 9 |
0/0 |
d |
0/0 |
nsf |
0/0 |
d, es |
0/0 |
d, es |
0/0 |
d, es |
day 10 |
0/0 |
d |
0/0 |
nsf |
0/0 |
d |
0/0 |
nsf |
0/0 |
d |
day 11 |
0/0 |
d (large area) |
0/0 |
nsf |
0/0 |
d |
0/0 |
nsf |
0/0 |
d |
day 12 |
0/0 |
d |
0/0 |
nsf |
0/0 |
d |
0/0 |
nsf |
0/0 |
d |
day 13 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
d |
day 14 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
day 15 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
Comments: E = erythema; O = oedema; 1, 2, 3, 4 = scoring system laid down in OECD Guideline 404 (Table 2) d =desquamation; es = eschar; s = scratches; nsf = no specific findings
|
Table Skin Irritation – Individual Data – Females:
Day after Start of Application |
Animal No. 26 |
Animal No. 27 |
Animal No. 28 |
Animal No. 29 |
Animal No. 30 |
|||||
E/O |
Comments |
E/O |
Comments |
E/O |
Comments |
E/O |
Comments |
E/O |
Comments |
|
day 2 |
1/1 |
nsf |
1/1 |
nsf |
2/1 |
nsf |
1/1 |
nsf |
2/1 |
nsf |
day 3 |
1/1 |
nsf |
1/0 |
nsf |
2/0 |
nsf |
2/0 |
es, fur stuck together |
1/0 |
fur stuck together |
day 4 |
0/0 |
nsf |
1/0 |
d |
1/0 |
d |
1/0 |
d, es |
1/0 |
d, fur stuck together |
day 5 |
0/0 |
nsf |
1/0 |
d |
0/0 |
d |
1/0 |
d |
1/0 |
d, al |
day 6 |
0/0 |
d |
0/0 |
d |
0/0 |
d |
0/0 |
d |
1/0 |
d, al |
day 7 |
0/0 |
d |
0/0 |
d, es |
0/0 |
d |
0/0 |
d |
2/0 |
d, al, es |
day 8 |
0/0 |
d, es |
0/0 |
nsf |
0/0 |
d, es |
0/0 |
nsf |
2/0 |
d, al, es |
day 9 |
0/0 |
d |
0/0 |
d |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
d, al, es |
day 10 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
es (large area), al |
day 11 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
es (large area), al, d |
day 12 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
es (1 cm2), al, d |
day 13 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
es (1 cm2), al, d |
day 14 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
d |
0/0 |
es (1 cm2), al, d |
day 15 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
d |
0/0 |
es (1 cm2), al, d |
Comments: E = erythema; O = oedema; 1, 2, 3, 4 = scoring system laid down in OECD Guideline 404 (Table 2) d =desquamation; es = eschar; s = scratches; al = alopecia both flanks where hair were stuck together the day before nsf = no specific findings
|
Table Absolute Body Weights in g and Body Weight Gain in %:
Dose: 2000 mg/kg body weight |
||||
Animal No. / Sex |
g |
g |
g |
% |
21 / male |
237 |
244 |
273 |
15 |
22 / male |
236 |
247 |
267 |
13 |
23 / male |
244 |
257 |
287 |
18 |
24 / male |
235 |
251 |
289 |
23 |
25 / male |
240 |
253 |
285 |
19 |
26 / female |
210 |
205 |
217 |
3 |
27 / female |
206 |
209 |
213 |
3 |
28 / female |
210 |
210 |
221 |
5 |
29 / female |
202 |
207 |
219 |
8 |
30 / female |
212 |
201 |
216 |
2 |
Table Macroscopic Findings - Individual Data – Males and Females:
Dose: 2000 mg/kg bw |
||
Animal No. / |
Organ |
Macroscopic Findings |
21 / male |
- |
nsf |
22 / male |
- |
nsf |
23 / male |
- |
nsf |
24 / male |
- |
nsf |
25 / male |
- |
nsf |
26 / female |
- |
nsf |
27 / female |
- |
nsf |
28 / female |
- |
nsf |
29 / female |
- |
nsf |
30 / female |
- |
nsf |
Table LD50:
Dose (Unit)
|
Number of Animals Investigated |
Number of Intercurrent Deaths |
LD50 |
2000 mg/kg bw |
5 males |
0 |
> 2000 mg/kg bw |
2000mg/kg bw |
5 females |
0 |
> 2000 mg/kg bw |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- Reliable and robust; GLP guideline study
Additional information
The acute toxicity of the registered substance was assessed in female rats via oral route and in female/male rats via dermal route.
The acute oral toxicity of the substance was tested by oral gavage of 25% solution in sesame oil to 10 female wistar rats per dose (1000 + 2000 mg/kg bw). At low dose 1/10 and at high dose 10/10 animals died within 1-5h after application. Therefore, the LD50 was determined to be in the range of 1000 -2000 mg/kg bw.
The acute dermal toxicity of the substance was tested by application of the test item to female and male rats at a dose of 2000 mg/kg bw. No mortality was observed during the study. No treatment related clinical signs were observed. Therefore, the dermal LD50 was determined to be greater than 2000 mg/kg bw.
Justification for classification or non-classification
Based on the available data, the registered substance was classified as R22 and Cat. 4 with hazard statement of H302: Harmful if swallowed, according to the criteria laid down in the EU Dangerous Substances Directive (67/548/EEC) and in the EU Classification Labelling and Packaging Regulation (1272/2008/EC).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)